| Acceptability | Targeting | Reliability | |||||||
---|---|---|---|---|---|---|---|---|---|---|
 | Item missing data (%)a | Possible range (midpoint) | Actual score range | Mean score (SD) | Floor/ceiling effects (%)b | Skewness | Cronbach’s alpha | Test-retestc | Mean IICd | Range IIC |
EINSTEIN DVT dataset | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Dutch version (n=332) | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
ACTS Burdens | 4 | 12–60 (36) | 34–60 | 53.4 (5.45) | 0/10 | –0.99 | 0.79 | 0.95 | 0.24 | 0.03–0.69 |
ACTS Benefits | 1 | 3–15 (9) | 3–15 | 10.5 (2.20) | 1/3 | −0.77 | 0.80 | 0.72 | 0.56 | 0.46–0.66 |
Italian version (n=217) | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
ACTS Burdens | 4 | 12–60 (36) | 33–60 | 52.4 (6.26) | 0/12 | −0.78 | 0.90 | 0.94 | 0.43 | 0.25–0.83 |
ACTS Benefits | 1 | 3–15 (9) | 3–15 | 10.7 (2.15) | 1/8 | 0.03 | 0.90 | 0.94 | 0.75 | 0.68–0.79 |
French version (n=222) | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
ACTS Burdens | 4 | 12–60 (36) | 33–60 | 55.6 (4.97) | 0/14 | −1.35 | 0.89 | 0.95 | 0.40 | 0.23–0.70 |
ACTS Benefits | 3 | 3–15 (9) | 3–15 | 11.5 (2.40) | 2/12 | −0.89 | 0.86 | 0.76 | 0.68 | 0.60–0.72 |
German version (n=243) | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
ACTS Burdens | 5 | 12–60 (36) | 34–60 | 52.0 (5.91) | 0/7 | −0.86 | 0.84 | 0.98 | 0.29 | 0.04–0.86 |
ACTS Benefits | 1 | 3–15 (9) | 3–15 | 12.2 (2.15) | 2/12 | −1.97 | 0.82 | 0.91 | 0.60 | 0.56–0.67 |
English version (n=322) e | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
ACTS Burdens | 0 | 12–60 (36) | 23–60 | 51.6 (6.78) | 0/7 | −1.12 | 0.86 | 0.98 | 0.36 | 0.12–0.67 |
ACTS Benefits | 0 | 3–15 (9) | 3–15 | 11.4 (2.50) | 1/14 | −0.62 | 0.87 | 0.91 | 0.70 | 0.59–0.74 |